Int J Mol Med 14:207215 Biernacka BA, Koceak P, Owczarek AJ, Choreza P, Puzianowska KM, Markuszewski L, Madej P, Chudek J, Olszanecka GM (2022) SHBG Prediction of insulin resistance and impaired fasting glucose based on Sex Hormone-Binding Globulin (SHBG) levels in polycystic ovary syndrome
Yes, Mounjaro is a GLP-1 medication, but its more accurate to describe it as a dual GLP-1/GIP receptor agonist
EClinicalMedicine 49 , 101436 (2022)
- Ramie G - Ramie G I was quite nervous, the word Cancer is extremely scary
Funding The research was supported by the Ministry of Science and Technology (Taiwan) (108-2314-B-002-032, 106-2314-B-002 -039 -MY3 and 108-2321-B-002 -035, 106-2319-B-492-001, 109-2327-B-002 -005, 109-2314-B-002 -103 -MY3, 109-2314-B-002 -064 -MY3), Program for Translational Innovation of Biopharmaceutical Development-Technology Supporting Platform Axis (AS-KPQ-106-TSPA) and Russian Science Foundation (Grant # 19-15-00010)
injections (between 15:00 and 17:00) of 100 nmol kg 1 MK-801, 10 nmol kg 1 semaglutide, 100 nmol kg 1 GLP-1MK-801 or vehicle, with concomitant measurements of body weight and food intake
